-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Orchestra BioMed Hldgs, Raises Price Target to $12

Benzinga·11/13/2026 11:57:10
Listen to the news
BTIG analyst Marie Thibault maintains Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Buy and raises the price target from $10 to $12.